Investigational New Drug Contract Development and Manufacturing Market size was valued at USD 10.5 Billion in 2024 and is forecasted to grow at a CAGR of 6.4% from 2026 to 2033, reaching USD 17.8 Billion by 2033.
The South Korea Investigational New Drug Contract Development and Manufacturing Market is experiencing significant growth, driven by the rising demand for outsourced pharmaceutical development services. As the global pharmaceutical industry expands, many companies are increasingly relying on South Korean contract development and manufacturing organizations (CDMOs) for support in the production of investigational new drugs (INDs). The market has garnered attention due to South Korea’s advanced infrastructure, regulatory environment, and cost-effective solutions for pharmaceutical companies worldwide. In this article, we will explore the types of services offered by CDMOs in South Korea and the specific requirements that industries seek when engaging in the Investigational New Drug Contract Development and Manufacturing Market.
The Investigational New Drug Contract Development and Manufacturing Market in South Korea is primarily driven by biotechnology companies, pharmaceutical companies, and contract research organizations (CROs). These organizations are seeking to streamline their drug development process by outsourcing the production of investigational new drugs to South Korean CDMOs. The market plays a critical role in assisting with preclinical and clinical trial phases, where companies require reliable manufacturing partners to ensure the safe and efficient production of investigational drugs.
There are several services offered within this market, including process development, formulation development, clinical trial material production, and large-scale commercial manufacturing. South Korean CDMOs also provide regulatory support, assisting companies in navigating the complex regulatory requirements of different regions, especially the U.S. and European Union. The ability to comply with Good Manufacturing Practice (GMP) standards is essential for these organizations, as it guarantees the safety and efficacy of drugs for clinical trials.
From an industry perspective, companies look for CDMOs that provide flexibility, high-quality manufacturing capabilities, and scalability. They also seek partners who are adept at handling the complexities of investigational new drug manufacturing, which includes managing raw material sourcing, facility capacity, and meeting project timelines. South Korean CDMOs have built a reputation for offering competitive pricing without compromising on quality, which makes them an attractive choice for companies aiming to keep development costs under control.
In the rapidly evolving pharmaceutical landscape, the Investigational New Drug Contract Development and Manufacturing Market in South Korea is positioned to continue growing as the demand for outsourced drug development services increases. Companies in the global pharmaceutical and biotech sectors are continually on the lookout for reliable manufacturing partners to accelerate their drug development timelines while ensuring the highest standards of quality and compliance.
Get an In-Depth Research Analysis of the South Korea Investigational New Drug Contract Development and Manufacturing Market Size And Forecast [2025-2032]
Â
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Investigational New Drug Contract Development and Manufacturing Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Investigational New Drug Contract Development and Manufacturing Market
Preclinical Phase
Clinical Phase (Phase I, II, III)
Commercialization Phase
Drug Substance Manufacturing
Drug Product Manufacturing
Regulatory Affairs Services
Quality Control and Assurance Services
Packaging and Labeling Services
Oncology
Cardiovascular Diseases
Neurological Disorders
Infectious Diseases
Autoimmune Disorders
Small-Scale Operations
Mid-Scale Operations
Large-Scale Operations
Pharmaceutical Companies
Biotechnology Firms
Academic and Research Institutions
CMOs (Contract Manufacturing Organizations)
Generic Drug Manufacturers
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Investigational New Drug Contract Development and Manufacturing Market Research Analysis
1. Introduction of the South Korea Investigational New Drug Contract Development and Manufacturing Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Investigational New Drug Contract Development and Manufacturing Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Investigational New Drug Contract Development and Manufacturing Market, By Type
6. South Korea Investigational New Drug Contract Development and Manufacturing Market, By Application
7. South Korea Investigational New Drug Contract Development and Manufacturing Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Investigational New Drug Contract Development and Manufacturing Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/